| Wong Wai Ling | 14-Jun-24 | | CoSec, J-CoSec. | | |
| Feng Honggang | 09-Feb-24 | | NED | | |
| Wang Xi | 18-Jan-23 | | ED | | |
| Sung Ka Woon | 18-Jan-23 | | INED | | |
| Wan Yushan | 09-Nov-22 | | CoSec | | |
| Song Rui Lin | 19-Nov-19 | | INED | | |
| Wang Jianguo | 19-Nov-19 | | INED | | |
| Wan Yushan | 19-Nov-19 | | FD | | |
| Wang Xinhua | 19-Nov-19 | | INED | | |
| Ren Jinsheng | 30-Nov-15 | | Ch, Fdr, CEO | | |
| Mak Cherie Po Man | 17-Sep-20 | 14-Jun-24 | CoSec | | |
| Ms. Mak Po Man Cherie | | 14-Jun-24 | J-CoSec. | | No reasons provided |
| Tang Renhong | 25-May-22 | 31-Dec-22 | CEO | | Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd. |
| Tang Renhong | 31-Dec-22 | 31-Dec-22 | ED | | Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd. |
| Tang Renhong | 19-Nov-19 | 31-Dec-22 | SVP | | Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd. |
| Tang Renhong | | 31-Dec-22 | Co-chief Executive Officer (Co-CEO) | | Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd. |
| Bao Jun | 10-Jun-20 | 09-Nov-22 | CoSec | | Due to his personal career development |
| Bao Jun | | 09-Nov-22 | J-CoSec. | | Due to his personal career development |
| Zhao John Huan | 19-Nov-19 | 31-Aug-22 | NED | | In order to devote more time to focus on his other business commitments |
| Feng Jie | 10-Jun-20 | 30-Jun-21 | CoSec | | |
| Zhang Cheng | 19-Nov-19 | 31-Mar-21 | ED, COO | | |
| Zhang Yi | | 01-Jun-20 | NED | | |
